Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy.

Authors

Michael Morris

Michael J. Morris

Memorial Sloan Kettering Cancer Center, New York, NY

Michael J. Morris , Patrick Hilden , Martin Edwin Gleave , Andrew J. Armstrong , Michael Anthony Carducci , Fred Saad , Erica Simone Dayan , Julie Filipenko , Ilyse Acosta , Glenn Heller , Howard I. Scher

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT01813370

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5011)

DOI

10.1200/jco.2015.33.15_suppl.5011

Abstract #

5011

Poster Bd #

3

Abstract Disclosures